GlassScriptPhysician profile
Anuj Thakre
NPI 1043987282
$2,633.45
in general payments reported to CMS, 2019-2025
8 companies · $1,848 in 2025
The $1,848 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $786 · 2025: $1,848.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,222 · Travel and Lodging: $1,077 · Education: $335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,221.50 |
| Travel and Lodging | $1,076.89 |
| Education | $335.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,013.90 | 2024-2025 | Merlin@Home, Ensite, Cardiomems |
| Inari Medical, INC. | $189.56 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abiomed | $142.39 | 2024 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $119.67 | 2024 | Lifevest |
| Medtronic, INC. | $65.82 | 2024-2025 | Corevalve Evolut R, Symplicity G3 |
| Boston Scientific Corporation | $50.72 | 2024-2025 | Accolade Sr, Watchman Flx |
| Shockwave Medical, INC | $26.03 | 2025 | |
| Pharmacosmos Therapeutics INC. | $25.36 | 2024 | Monoferric |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anuj Thakre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.